Market revenue in 2023 | USD 142.9 million |
Market revenue in 2030 | USD 214.0 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Regulatory writing & publishing |
Fastest growing segment | Legal Representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Icon PLC, Wuxi AppTec Co Ltd, Charles River Laboratories International Inc, Cencora Inc, Pharmexon, Genpact Ltd, Freyr Solutions, PAREXEL |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical regulatory affairs market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 36.53% in 2023. Horizon Databook has segmented the Canada pharmaceutical regulatory affairs market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, other services covering the revenue growth of each sub-segment from 2018 to 2030.
A rising number of market entrants may result in an increased demand for regulatory services. Canada accounts for around 4.0% of the total number of clinical trials and is ranked fourth in terms of clinical sites.
The presence of a well-established healthcare system and favorable government regulations are expected to improve the number of clinical trials in Canada. These factors are anticipated to contribute to the demand for pharmaceutical regulatory affairs services in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada pharmaceutical regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Canada pharmaceutical regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account